CADR is more common in HIV-infected persons, although the incidence is declining because of the new safer drugs and early initiation of antiretroviral therapy. The presentation and clinical course does not seem to differ from that in the general population. Antiretrovirals, antituberculosis drugs, and drugs for treating opportunistic infections are most commonly implicated. HIV-associated CADR poses major diagnostic and management challenges because of polypharmacy, overlapping drug toxicities, drug interactions, overlap of CADR with other diseases, and limited alternative drugs. We discuss pragmatic management strategies of HIV-associated CADR focusing on resource-limited settings, where HIV infection and associated CADR are most common.
CITATION STYLE
Lehloenya, R. J., & Peter, J. (2018). Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Infection. In Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends (pp. 197–205). Springer Singapore. https://doi.org/10.1007/978-981-13-1489-6_13
Mendeley helps you to discover research relevant for your work.